X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

    Cytiva and NecstGen form strategic collaboration to accelerate development of cell and gene therapies

    Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials

    Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma's VP3 Nasal Spray System

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma’s VP3 Nasal Spray System

    Cryoport and Cell Matters Enter into Strategic Partnership

    Cryoport and Cell Matters Enter into Strategic Partnership

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19

    Gilead Sciences Announces FDA Approval of Veklury for Treatment of Non-Hospitalized Patients at High Risk for COVID-19

    Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

    Australia Therapeutic Goods Administration Grants Provisional Registration for Novavax COVID-19 Vaccine

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

    Cytiva and NecstGen form strategic collaboration to accelerate development of cell and gene therapies

    Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials

    Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma's VP3 Nasal Spray System

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma’s VP3 Nasal Spray System

    Cryoport and Cell Matters Enter into Strategic Partnership

    Cryoport and Cell Matters Enter into Strategic Partnership

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19

    Gilead Sciences Announces FDA Approval of Veklury for Treatment of Non-Hospitalized Patients at High Risk for COVID-19

    Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

    Australia Therapeutic Goods Administration Grants Provisional Registration for Novavax COVID-19 Vaccine

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Europe

Chemspec Europe 2018opens its doors tomorrowin Cologne and presents the full range of fine and speciality chemicals

Content Team by Content Team
20th June 2018
in Europe, News

Chemspec Europe, the 33rdInternational Exhibition for Fine and Speciality Chemicals, will take place from 20–21 June 2018, atKoelnmesse in Cologne, Germany. On a net exhibition space of over 6,000 square metres, a total of 358 exhibitors from 27 countries will present a product portfolio that covers thefullspectrum of fine and speciality chemicals for various applications. Furthermore, visitorscan expectnew intelligent networking opportunities with the Chemspec Europe Partnering Programme as wellas a comprehensive conference programme.

Chemspec Europe is Europe’s leading fine and speciality chemicals exhibition. For purchasers and agents looking for specific ingredients or bespoke solutions, the event is a renowned marketplace to source products, exchange expertise and build international contacts.

On a net floor space of over 6,000 square metres,358 exhibitors will showcase their products and services coveringa maximumrange of fine and speciality chemicals, including pharmaceuticals, agrochemicals, bio-based chemicals, polymers, additives, advanced intermediates, food and feed, oil and gas mining, pigments, dyes, electronics, fragrances, household chemicals and many more.

The broad exhibition portfolio is completed by a range of analytical, production and processing equipment as well as regulatory services and products. Major European exhibitor countries are Germany, the UK, France, Belgium and Switzerland. Non-European exhibitors mainly come from China, India and the USA.

“Chemspec Europe is the only specialised platform for the fine and speciality chemicals industry in Europe. The event is focussing upon prevailing trends and developments in the industry sector, with a particular focus upon current challenges and emerging opportunities.Currently, there is an increasing trend for bio-based chemicals for the development of fine and speciality chemicals. Furthermore, intensified competition and the constant search for innovation are some of the key drivers that make flexible production and strategic collaborations more and more important. Only well-informed companies with an excellent network can besuccessful in this highly complex market in the long run”, says Liljana Goszdziewski, Exhibition Director of Chemspec Europe, on behalf of the organisers,Mack Brooks Exhibitions.

12425_Chemspec_Europe1

Intelligent networking with the newChemspec Europe Partnering Programme
Networking has always been an essential part of Chemspec Europe. This year, visitors have the opportunity to use thenew Chemspec Europe Partnering Programmewhich allows them to connect and do business with people of complementary interests.

A matchmaking service allows visitors,who are looking for specific business solutions, products or services, to select contacts by keywords and arrange meetings with attendees who provide such solutions. For the arranged meetings, visitors can use the new on-site meeting spaces which are exclusively available to participants of the Partnering Programme.

Interested visitors can first register as a visitor via the Chemspec Europe website www.chemspeceurope.com und then subscribe to the Partnering Programme (subject to a charge).

Conferencesand workshops: Industry experts discuss current developments and future prospects
The accompanying conference programme complements the topical variety of the exhibition. In four lecture theatres, a total of 56 conference sessions and workshops provide insights into current developments and prospects and encourage discussions and networking with international industry colleagues.

In the Agrochemical Lecture Theatre, which is sponsored by AGROW, the“Agrochemical Outlook Conference” offers lectures on „Challenges and Opportunities in 2018“.

On Wednesday, 20 June 2018, 14:00–17:00, seven young startups will present their innovations on “New Paths to Fine and Specialty Chemicals”. The “Innovative Startups” conference takes place in association with BCNP Consultants and includes short presentations as well as a panel discussion.

In the Pharma Lecture Theatre, several speakers will give lectureson trends and challenges in the pharmaceutical industry. On Wednesday, 20 June 2018 at 9:30, Dr.MagidAbou-Gharbia, Moulder Center for Drug Discovery Research, will give a presentation on the topic“Drug discovery, then and now: The road to personalized medicine”.On both exhibition days, there will also be the “Pharma Outsourcing Best Practices Panel“whose panellists include particularly high-calibre guests.

The two-day RSC Symposium of the Royal Society of Chemistry includes lectures about ”Enhanced Performance using Additives – Choosing the Best Additive”. In the Regulatory Services Lecture Theatre everything will revolve around “Getting ready for REACH 2018 – Regulatory Challenges”.

The day bevor the official start of the exhibition, on Tuesday, 19 June 2018, from 14:00–17:30, EFCG (The European Fine Chemicals Group) will return with “Crop Protection & Fine Chemicals Forum”. For this conference, a registration is required in advance via the Chemspec Europe website.

The detailed conference programme can be found on the exhibition website www.chemspeceurope.com.

Information for visitors
Chemspec Europe 2018will take place in hall 8 of the Koelnmesse in Cologne, Germany, which can be accessedvia the NorthEntrance (“EingangNord”). Opening hours on both exhibition days are from 9:00–17:00.

In the recently published Chemspec Europe Show Preview more than two hundred exhibiting companies provide a detailed overview of the product and services which will be presented at this year’s exhibition. The online version of the bilingual brochure is available on the Chemspec Europe website.

Ticket registration is available on the exhibition website www.chemspeceurope.com. Online tickets for Chemspec Europe 2018 are free. On-site, a ticket will cost €50. Tickets are valid for both exhibition days and include entry to the conferences.

Previous Post

The EU approves Tagrisso for 1st-line treatment of EGFR-mutated non-small cell lung cancer

Next Post

Record-breaking MEDICAL FAIR ASIA: The comprehensive sourcing and knowledge sharing platform

Related Posts

Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.
News

Indian Scientists Claim To Design Vaccine For All Variants

9th February 2022
Drones for Delivery To Carry Pharmaceutical Weight Forward
News

Drones for Delivery To Carry Pharmaceutical Weight Forward

9th February 2022
America Facing Heart Health Issues Since The Pandemic Began
News

America Facing Heart Health Issues Since The Pandemic Began

8th February 2022
T2 Biosystems T2SARS-CoV-2 Panel Detects Omicron Subvariants
News

T2 Biosystems T2SARS-CoV-2 Panel Detects Omicron Subvariants

7th February 2022
OLUMIANT® (baricitinib) 2-mg Tablets gets FDA approval to treat adult patients with moderately to severely active Rheumatoid Arthritis
Manufacturing

Lilly announces $1 billion investment in new manufacturing facility in North Carolina

7th February 2022
Recipharm supports FDA approval of Perrigos AB-rated generic product
News

Recipharm acquires GenIbet to bolster Biologics offering

7th February 2022
Next Post

Record-breaking MEDICAL FAIR ASIA: The comprehensive sourcing and knowledge sharing platform

Latest News

Envirotainer introduces the RAP for the future - part of the Releye series
Packaging & Logistic

Envirotainer introduces the RAP for the future – part of the Releye series

14th February 2022
United Cargo Meets Growing Demand for Pharmaceuticals with New TempControl Containers
Packaging & Logistic

Opticooler receives technical approval by Japanese major airlines

14th February 2022
Aptar Pharma Launches HeroTracker Sense, Novel Connected Smart Device for Respiratory Disease
Press Statements

Aptar Pharma Launches HeroTracker Sense, Novel Connected Smart Device for Respiratory Disease

14th February 2022
Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.
News

Indian Scientists Claim To Design Vaccine For All Variants

9th February 2022
Drones for Delivery To Carry Pharmaceutical Weight Forward
News

Drones for Delivery To Carry Pharmaceutical Weight Forward

9th February 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In